glp-1 bowel obstruction lawyer in louisiana gastrointestinal lawsuit GLP-1 RA Lawsuit louisiana semaglutide digestive blockage law

Description

As a weight-loss tool, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used in patients with obesity, which is a risk factor for cancers like colorectal and gastrointestinal

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

Learn about the FDA-documented link between semaglutide (Ozempic, Wegovy) and gallbladder disease, including gallstones and cholecystitis

This condition carries a global mortality rate of approximately 8% and is characterized by significantly elevated creatine kinase (CK) levels, often rising to five times the normal upper limit or higher